Do, T. X., Nguyen, H. T., Nguyen, P. T. L., Kieu, M. T. T., Duong, T. V., Pham, V. N. H. (2026). Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country. PLoS ONE. https://doi.org/10.1371/journal.pone.0345212